Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737

Immunotoxins are antibody–toxin fusion proteins directed to kill cancer cells displaying specific target antigens on their surface. Remarkably, immunotoxins directed to CD22 on hairy cell leukemia have produced complete remissions in approximately 60% of patients enrolled in phase I/II trials. For r...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Leuk Lymphoma
Main Authors: FITZGERALD, DAVID J., MOSKATEL, ELIZABETH, BEN-JOSEF, GAL, TRAINI, ROBERTA, TENDLER, TARA, SHARMA, ASHIMA, ANTIGNANI, ANTONELLA, MUSSAI, FRANCIS, WAYNE, ALAN, KREITMAN, ROBERT J., PASTAN, IRA
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7450489/
https://ncbi.nlm.nih.gov/pubmed/21599608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2011.569961
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares